Hall v. DuPont De NeMours, Inc.

CourtDistrict Court, S.D. Ohio
DecidedAugust 1, 2024
Docket2:23-cv-00869
StatusUnknown

This text of Hall v. DuPont De NeMours, Inc. (Hall v. DuPont De NeMours, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hall v. DuPont De NeMours, Inc., (S.D. Ohio 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

IN RE: E. I. DU PONT DE NEMOURS AND COMPANY C-8 PERSONAL

INJURY LITIGATION Case No. 2:13-md-2433 JUDGE EDMUND A. SARGUS, JR. Magistrate Judge Elizabeth A. Preston Deavers

This document relates to: Joseph and Donna Hall v. E. I. du Pont de Nemours and Co., et al., Case No. 2:23-cv-869

DISPOSITIVE MOTIONS ORDER

Motion for Summary Judgment on Leach Class Membership (Hall, Case No. 2:23-cv-869, ECF No. 21)

This matter is before the Court on a Motion for Summary Judgment on Leach Class Membership filed by Plaintiffs Joseph and Donna Hall. (Mot., ECF No. 21.) Defendant E.I. Du Pont de Nemours and Company (“DuPont”) opposes (Resp., ECF No. 44), and Plaintiffs filed a reply (Reply, ECF No. 58). For the reasons stated below, the Motion is GRANTED. I. BACKGROUND The Court assumes the reader’s familiarity with this multi-district litigation (“MDL”) that began in 2013 as a result of DuPont’s discharge of C-8, or perfluorooctanoic acid (PFOA), into the Ohio River, landfills, and air surrounding its plant in West Virginia. Thus, the Court provides only the background information necessary to understand the issues raised in Plaintiffs’ Motion. A comprehensive account of the history surrounding DuPont’s discharges of C-8 and the lengthy litigation that has ensued is available in In re E. I. du Pont de Nemours & Co. C-8 Pers. Inj. Litig., 54 F.4th 912, 916–21 (6th Cir. 2022), cert. denied sub nom. E. I. du Pont de Nemours & Co. v. Abbott, 144 S. Ct. 16, 217 L. Ed. 2d 229 (2023). A. The Halls and Their Lawsuit Mr. Hall and his spouse, Mrs. Hall, brought this action on March 3, 2023. (Compl., ECF No. 1.) They allege that Mr. Hall resided and worked in at least one of the contaminated water districts

including the City of Little Hocking, Ohio and Little Hocking Water Association, Ohio (“LHWA”) in or around 1999 and consumed water contaminated with C-8 at greater than .05 ppb for at least a year before December 3, 2004. (Id. ¶ 8.) As a result of his water consumption, Plaintiffs allege Mr. Hall was diagnosed with testicular cancer on February 10, 2022, and sustained severe and permanent personal injuries, pain, suffering, and emotional distress. (Id. ¶ 9.) Plaintiffs brought causes of action against DuPont1 for negligence; concealment, misrepresentation, and fraud; negligent and intentional infliction of emotional distress; punitive damages; and loss of consortium. (Id. ¶¶ 157–204.) Since the complaint was filed, Plaintiffs filed a notice of dismissal under Federal Rule of Civil Procedure 41(a)(1)(A) of Plaintiffs’ claim for

concealment, misrepresentation, and fraud. (ECF No. 7.) Because the notice did not dismiss all claims, the Court construed the notice as a joint motion to sever under Federal Rule of Civil Procedure 21, granted the motion, and dismissed the second cause of action without prejudice. (ECF No. 9.) B. The Leach Class Action and Settlement This Court summarized the Leach class action and settlement in Dispositive Motions Order (“DMO”) No. 1 (Main MDL, Case No. 2:13-md-2433, ECF No. 1679): On August 31, 2001, a group of individuals filed a state court action in West Virginia against [DuPont] captioned Leach v. E. I. du Pont de Nemours & Co., No. 01- C-698 (Wood County W. Va. Cir. Ct.) (“Leach Case”). The plaintiffs in the Leach Case brought a variety of claims under West Virginia common law tort theories for equitable, injunctive and declaratory relief, along with compensatory and punitive damages, as a result of alleged drinking water contamination.

1 The parties jointly moved to dismiss without prejudice Defendant The Chemours Company (ECF On April 10, 2002, the West Virginia trial court (“Leach Court”) granted the plaintiffs’ motion for class certification and certified a mandatory, non-opt-out class

on behalf of a class of all persons whose drinking water is or has been contaminated with ammonium perfluorooctanoate (a/k/a/ “C-8”) attributable to releases from DuPont’s Washington Works plant (hereinafter “the Class”) with respect to all issues relating to [DuPont’s] underlying liability and Plaintiffs’ claims for equitable, injunctive, and declaratory relief, including liability for punitive damages; all damage issues involving any determination of individual harm of the Class members and the amount of any punitive damages are hereby STAYED and RESERVED for later litigation . . . .

Leach v. E.I. Du Pont de Nemours & Co., No. 01-C-608, 2002 WL 1270121, at *1 (W. Va. Cir. Ct. Apr. 10, 2002). The class included approximately 80,000 individual residents of the communities served by certain public water districts and private water sources that had allegedly been contaminated with C-8 discharged from DuPont’s Washington Works plant.

In November 2004, the parties entered into a class-wide settlement of the Leach Case (“Leach Settlement Agreement”). On February 28, 2005, following appropriate class-wide notice, objection opportunities, full opt-out opportunities, and a final fairness hearing, the Leach Court entered a final order approving the Leach Settlement Agreement.

In the Leach Settlement Agreement, the parties fashioned a unique procedure to determine whether the approximately 80,000 individual class members would be permitted to file actions against DuPont based on any of the human diseases they believed had been caused by exposure to C-8. The procedure required DuPont and the plaintiffs to jointly select three completely independent, mutually-agreeable, appropriately credentialed epidemiologists (“Science Panel”) to study human disease among the residents exposed to C-8 by the discharges from DuPont’s Washington Works plant. (Leach Settlement Agreement “S.A.” at §§ 12.2.1, 12.2.2; ECF No. 520- 8.) The Leach Settlement Agreement defines the task as follows:

The Science Panel shall develop and approve, by a vote of at least two members of the Science Panel, a protocol for a study of Human Disease among residents exposed to C-8 in the communities served by the Public Water District and Covered Private Sources and shall have the responsibility for conducting such study in accordance with such protocol (the “Community Study”).

(S.A. § 12.2.2.)

Pursuant to the Leach Settlement Agreement, the parties chose the Science Panel, which established a protocol and studied numerous human diseases. The Agreement provided that the results of the Science Panel’s study would be issued in either a “Probable Link Finding” or a “No Probable Link Finding” for each human disease the Panel studied. (S.A. § 12.2.3.)

In 2011 and 2012, the Science Panel delivered Probable Link Findings for the following human diseases (“Linked Diseases”): kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, diagnosed high cholesterol (hypercholesterolemia), and pregnancy-induced hypertension and preeclampsia. The Leach Settlement Agreement defines “Probable Link Finding” as follows:

“Probable Link” shall mean that based upon the weight of the available scientific evidence, it is more likely than not that there is a link between exposure to C-8 and a particular Human Disease among Class Members.

(S.A. § 1.49.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Hall v. DuPont De NeMours, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/hall-v-dupont-de-nemours-inc-ohsd-2024.